Biocept (BIOC) Reports Q3 Loss of $0.57/Share

Biocept (NASDAQ: BIOC) reported Q3 EPS of ($0.57), versus ($0.72) reported last year. Revenue for the quarter came in at $1.05 million, versus $165 thousand reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Veralto Corporation (VLTO) Tops Q1 EPS by 6c, Offers Guidance
• Premier Financial (PFC) Tops Q1 EPS by 3c